278 related articles for article (PubMed ID: 17157920)
21. Insomnia, platelet serotonin and platelet monoamine oxidase in chronic alcoholism.
Nenadic Sviglin K; Nedic G; Nikolac M; Mustapic M; Muck-Seler D; Borovecki F; Pivac N
Neurosci Lett; 2011 Aug; 500(3):172-6. PubMed ID: 21722708
[TBL] [Abstract][Full Text] [Related]
22. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
[TBL] [Abstract][Full Text] [Related]
23. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology.
Rothermundt M; Missler U; Arolt V; Peters M; Leadbeater J; Wiesmann M; Rudolf S; Wandinger KP; Kirchner H
Mol Psychiatry; 2001 Jul; 6(4):445-9. PubMed ID: 11443531
[TBL] [Abstract][Full Text] [Related]
24. Cytochemical determination of monoamine oxidase activity in lymphocytes and neutrophils of schizophrenic patients.
Tsavaris N; Konstantopoulos K; Vaidakis S; Koumakis K; Pangalis G
Haematologia (Budap); 1995; 26(3):143-6. PubMed ID: 7797144
[TBL] [Abstract][Full Text] [Related]
25. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women.
Muck-Seler D; Pivac N; Mustapic M; Crncevic Z; Jakovljevic M; Sagud M
Psychiatry Res; 2004 Jul; 127(3):217-26. PubMed ID: 15296821
[TBL] [Abstract][Full Text] [Related]
26. Atypical antipsychotics and the relevance of glutamate and serotonin.
van der Heijden FM; Tuinier S; Fekkes D; Sijben AE; Kahn RS; Verhoeven WM
Eur Neuropsychopharmacol; 2004 May; 14(3):259-65. PubMed ID: 15056486
[TBL] [Abstract][Full Text] [Related]
27. Poor outcome and low platelet MAO activity in chronic schizophrenia.
Bierer L; Docherty JP; Young JG; Giller E; Cohen D
Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867
[TBL] [Abstract][Full Text] [Related]
28. Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurements.
Snell LD; Glanz J; Tabakoff B;
Alcohol Clin Exp Res; 2002 Jul; 26(7):1105-13. PubMed ID: 12170121
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of platelet histamine and serotonin with their corresponding plasma oxidases in asthmatics with normals.
Matkar NM; Rupwate RU; Desai NK; Kamat SR
J Assoc Physicians India; 1999 Sep; 47(9):878-82. PubMed ID: 10778656
[TBL] [Abstract][Full Text] [Related]
30. Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia.
Jeste DV; Neckers LM; Wagner RL; Wise CD; Staub RA; Rogol A; Potkin SG; Bridge TP; Wyatt RJ
J Clin Psychiatry; 1981 Feb; 42(2):75-7. PubMed ID: 6109719
[TBL] [Abstract][Full Text] [Related]
31. Platelet monoamine oxidase kinetics, alcoholism subtypes and cigarette smoking.
Cicin-Sain L; Matosic A; Mokrovic G; Balija M; Marusic S; Jernej B
Neuropsychobiology; 2007; 56(2-3):138-45. PubMed ID: 18259087
[TBL] [Abstract][Full Text] [Related]
32. Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder.
Pivac N; Knezevic J; Kozaric-Kovacic D; Dezeljin M; Mustapic M; Rak D; Matijevic T; Pavelic J; Muck-Seler D
J Affect Disord; 2007 Nov; 103(1-3):131-8. PubMed ID: 17289152
[TBL] [Abstract][Full Text] [Related]
33. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population.
Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ
Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472
[TBL] [Abstract][Full Text] [Related]
34. [Clozapine, cytokines, fever and sleep].
Hinze-Selch D; Mullington J; Pollmächer T
Wien Med Wochenschr; 1996; 146(13-14):311-3. PubMed ID: 9012164
[TBL] [Abstract][Full Text] [Related]
35. Does clozapine decrease smoking?
de Leon J; Diaz FJ; Josiassen RC; Cooper TB; Simpson GM
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):757-62. PubMed ID: 15951089
[TBL] [Abstract][Full Text] [Related]
36. "... But I can still sue you, can't I"?
Friedman JH
Med Health R I; 2007 Jun; 90(6):170. PubMed ID: 17633586
[No Abstract] [Full Text] [Related]
37. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
38. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines.
Takahashi S; Yamane H; Tani N
Folia Psychiatr Neurol Jpn; 1975; 29(3):207-14. PubMed ID: 2524
[TBL] [Abstract][Full Text] [Related]
39. [Clozapine in the treatment of schizophrenia].
Raitasuo V
Duodecim; 2000; 116(11):1199-204; quiz 1205. PubMed ID: 11989005
[No Abstract] [Full Text] [Related]
40. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
